Muscle Energy Technique on Forward Head Posture and Cervical Mobility in Visually Impaired Children
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04716348 |
|
Recruitment Status :
Recruiting
First Posted : January 20, 2021
Last Update Posted : May 11, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Children With Visual Disabilities | Procedure: muscle energy technique | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 40 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Treatment |
| Official Title: | Efficacy of Muscle Energy Technique on Forward Head Posture and Cervical Mobility in Visually Impaired Children |
| Actual Study Start Date : | February 1, 2021 |
| Estimated Primary Completion Date : | June 1, 2021 |
| Estimated Study Completion Date : | June 1, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: group A
suboccipital muscle energy technique
|
Procedure: muscle energy technique
muscle energy technique for suboccipital muscles |
|
Sham Comparator: group B
sham muscle energy technique
|
Procedure: muscle energy technique
muscle energy technique for suboccipital muscles |
- change in craniovertebral angle [ Time Frame: baseline pre intervention and immediately after the intervention ]analysis of craniovertebral angle form lateral view performed by AUTOCAD program
- change of cervical range of motion [ Time Frame: baseline pre intervention and immediately after the intervention ]measurement of cervical range of motion including cervical flexion, cervical extension, cervical side bending, and cervical rotation. these measurement will be applied by CROM device
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 8 Years to 14 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Visual acuity will be 6/24, 6/36 and 6/60 after correction.
- Wearing glasses more than one year.
- Craniovertebral angle < 50°.
- Functional hearing.
Exclusion Criteria:
- Injury of cervical region (e.g: atlantoaxial instability).
- Cervical spine deformities or/disorders.
- History of previous cervical spine surgery.
- Rheumatic and congenital heart disease.
- Regular participation in any sport activities.
- Intellectual or/mental disabilities
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04716348
| Contact: Noha S Elserty, PhD | +201006709648 | noha_elserty@hotmail.com | |
| Contact: Eman W Mahmoud, PhD | +201008079576 | Eman.wagdy@pt.bsu.edu.eg |
| Egypt | |
| Noha Elserty | Recruiting |
| Cairo, Egypt | |
| Contact: Noha S Elserty | |
| Principal Investigator: | Noha S Elserty, PhD | Lecturer of physical therapy- Egyptian Chinese University |
| Responsible Party: | Noha Elserty, lecturer of physical therapy, Egyptian Chinese University |
| ClinicalTrials.gov Identifier: | NCT04716348 |
| Other Study ID Numbers: |
Egyptian Chinese University |
| First Posted: | January 20, 2021 Key Record Dates |
| Last Update Posted: | May 11, 2021 |
| Last Verified: | May 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | supporting information that will be shared after publication of the study |
| Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) |
| Time Frame: | after publishing the study |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

